Successful clozapine retrial after suspected myocarditis

American Journal of Psychiatry

Volumn 167, Issue 3, 2010, Pages 350-351

  Rosenfeld, Andrew J ^a   Gibbs, Tresha ^a   Ivie, Ryan ^a   Clarke, Laura ^a   Merrill, David B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MYOCARDITIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHIZOAFFECTIVE PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; HUMANS; MALE; MYOCARDITIS; PSYCHOTIC DISORDERS; RETREATMENT;

EID: 77649139857     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09081118     Document Type: Letter

References (3)

1. Kilian JG, Kerr K, Lawrence C, Celermajer DS: Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354:1841-1845
2. Merrill DB, Dec GW, Goff DC: Adverse cardiac effects associated with clozapine. J Clin Psychopharm 2005; 25:32-41
3. Reinders J, Parsonage W, Lange D, Potter JM, Plever S: Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service. Aust N Z J Psychiatry 2004; 38:915-922